Global Companion Animal Arthritis Market Overview 2033 : Forecasted Market Size And Growth Rate | Zoetis Inc., Virbac S. A., Elanco Animal Health Incorporated, C. H. Boehringer Sohn AG & Co. KG

"The companion animal arthritis market size has grown strongly in recent years. It will grow from $3.4 billion in 2023 to $3.72 billion in 2024 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to increasing pet ownership, advancements in veterinary medicine, awareness and education.

The companion animal arthritis market size is expected to see rapid growth in the next few years. It will grow to $5.47 billion in 2028 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to aging pet population, innovations in therapeutics, customized nutrition, telemedicine in veterinary care, humanization of pets. Major trends in the forecast period include biologics in veterinary medicine, digital health solutions, nutraceuticals and functional foods, collaborations and partnerships, pet insurance impact, consumer demand for natural and holistic therapies, data-driven veterinary care.

Market Overview -
The companion animal arthritis refers to a condition involving inflammation of one or more joints in companion animals such as cats, dogs, and other exotic animals. Companion animal arthritis develops in the bones when the cartilage between joints becomes rougher and more worn, forcing the bone surfaces to rub against one another.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=7772&type=smp

Growing Trend Of Pet Adoption Boosts The Companion Animal Arthritis Market
Rising trend of pet adoption is expected to propel the growth of companion animal arthritis market. Pet adoption helps reduce stress, anxiety, depression, and so on. Pet adoption is a method of getting a dog, cat, and other exotic animals that their prior owners have given up to a shelter or rescue rather than getting one from a pet shop, breeder, or another individual. Pets face the risk of developing arthritis once they start getting into old age. For instance, according to a survey conducted by, The American Pet Products Association, a US-based not-for-profit industry association, approximately half of british homes with pets acquired at least one new animal while the country was in lockdown, while 11.3 million Americans acquired new pets during the pandemic. Additionally, in the survey, 16% of Generation Z respondents and 13% of millennials stated they had adopted a new pet during the pandemic. Therefore, the rising trend of pet adoption contributes significantly to the growth of the companion animal arthritis market.

Competitive Landscape -
Major companies operating in the companion animal arthritis market report are Zoetis Inc., Virbac S. A., Elanco Animal Health Incorporated, C. H. Boehringer Sohn AG & Co. KG, Ceva Santé Animale, Dechra Pharmaceuticals PLC, Vetoquinol S. A., Phibro Animal Health Corporation, NexGen Pharmaceuticals Inc., Norbrook Holdings Limited, Covetrus Inc., Bayer AG, Abbott Laboratories, Qiagen N. V., Becton Dickinson and Company, Quest Diagnostics Incorporated, Hologic Inc., F. Hoffmann-La Roche Ltd., Femasys Inc., Arbor Vita Corporation, VetStem Biopharma Inc., Aratana Therapeutics Inc., Kindred Biosciences Inc., Karyopharm Therapeutics Inc., Regeneus Ltd., VetCell Therapeutics, VetDC Inc., VetPharm Inc., VetStem, VetZ Limited, VetZoo

Advancements In Monoclonal Antibody Therapy For Companion Animal Arthritis Treatment
Technological innovation is a key trend in the companion animal arthritis market. Technological innovation benefits people by improving productivity and giving them access to freshly produced better goods and services, which raise the general standard. Major players in the industry are using monoclonal antibody therapy to treat companion animal arthritis. Monoclonal antibody therapy is used on companion animals to treat arthritis, immune-mediated disorders, chronic pain, and others. Monoclonal antibodies are antibodies produced by immune cells that are identical clones of a single parent cell. For instance, In April 2021, Zoetis, a US-based pharmaceutical company, launched LIBRELA® and SOLENSIA® in European Union, United Kingdom, and Switzerland to prevent arthritis pain in cats and dogs using monoclonal antibody therapy. It works similarly to naturally produced antibodies, with little involvement of the liver or kidneys in their metabolism and removal of gastrointestinal impact.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/companion-animal-arthritis-global-market-report

Key Segments -
The companion animal arthritis market covered in this report is segmented -
1) By Type: Dogs, Cats, Other Types
2) By Indication: Osteoarthritis, Other Arthritis
3) By Treatment: Medication, Supplements, Other Treatments
4) By Distribution Channel: Veterinary Hospitals And Clinics, Retail Pharmacies, Online Stores, Other Distribution Channels

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model "

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.